Navigation Links
Amgen Announces Webcast of 2009 Second Quarter Financial Results
Date:7/23/2009

THOUSAND OAKS, Calif., July 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it plans to report its second quarter financial results on Monday, July 27, 2009 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's Web site, www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay 72 hours after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen re
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
2. Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
3. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
4. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
5. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
6. Amgen to Present at the Goldman Sachs Global Healthcare Conference
7. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
8. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
9. Amgen Highlights Data to Be Presented at ASCO
10. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
11. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 Follow us on ... has revolutionized disease treatment on account of their better ... diseases, such as rheumatoid arthritis. The industry is expected ... traditional small molecule drugs to biopharmaceuticals over the coming ... cell and gene therapies, and recombinant proteins has attracted ...
(Date:6/3/2015)... On June 22, 2015, Medicare will ... sensitivity (pharmacogenetic) testing that it has reimbursed since 2009. ... 19 million of the 49 million Medicare beneficiaries in the ... adverse drug events.(1) Sadly, if it became a standard of ... the use of an individual’s genetic information to tailor treatment, ...
(Date:6/3/2015)... On the heels of a report predicting bioinformatics ... click here to review news coverage about the report ... has the talent to become a world-leading center of the ... biological data are collected and analyzed to help scientists discover ... elements of a perfect storm for bioinformatics leadership,” said Dr. ...
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Dr. Steven ... York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, ... on weekdays to his practice. In most cases, depending on ... of the day they call, they will be seen by ... first priority as a cardiologist is to ensure that people ...
Breaking Medicine News(10 mins):Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2
... study published in the Lancet, researchers had suggested that ... HPV virus might vary from country to country all ... developed against two types of virus that cause cervical ... high-risk HPV infections in Europe than sub-Saharan Africa. ...
... with the new biologic drug adalimumab and methotrexate has ... for people with long-standing rheumatoid arthritis when compared to ... been found to decrease pain and swelling in patients ... ,At the end of the 6-month trial, 43 percent ...
... could be happier than the poor taking into consideration factors ... ,The study was conducted on a group of people ... were questioned regarding their age, total family income and general ... older, race and marital status. ,The analysis of ...
... the state administration of Maharastra who have been under ... floods are now under defensive and are controlling the ... health authorities have reported fewer admissions of new ... such as leptospirosis and dengue showed signs of abating. ...
... men with early stage prostate cancer who make drastic changes ... reverse the progression of their illness say researchers//. The study ... that lifestyle changes may affect the progression of a cancer. ... in men after lung cancer. For the study researchers recruited ...
... latest BMJ said that results of a randomized controlled ... help pregnant smokers quit or cut down had yielded ... mothers//. ,A third of pregnant women smoke and ... support to help them quit. Motivational interviewing - a ...
Cached Medicine News:Health News:Trained Counselors Counseling Pregnant Smokers To Quit May Not Work 2
(Date:6/3/2015)... , June 3, 2015  Flow cytometry remains ... the globe and keeping track of wide-ranging consumer ... market. In particular, ensuring user-friendliness, fluorescence capabilities, specialized ... the most important factors influencing end-user purchase decisions ... New analysis from Frost & Sullivan, ...
(Date:6/3/2015)... 3, 2015  VA North Texas Health Care ... of vBloc, a technology-based, scientifically advanced weight loss ... implant called the Maestro® Rechargeable System that intermittently ... messages involving food intake and processing between the ... and customizable to meet the needs of a ...
(Date:6/3/2015)... June 3, 2015  SurgiQuest®, Inc. ("SurgiQuest", the ... for minimally invasive surgery (MIS) announced today that ... over 250,000 procedures.  Adoption has risen rapidly with ... year, driven by the company,s expansion from robotics ... geographic expansion to over 45 countries.   ...
Breaking Medicine Technology:Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3Rapid Procedure Growth With SurgiQuest's AirSeal System 2
... Incorporated (Nasdaq: ARAY ), a global ... Senior Vice President, General Counsel and Corporate Secretary, Darren ... by the Silicon Valley/San Jose Business Journal and ... their ,Best Bay Area Corporate Counsel Awards,. This annual awards ...
... 25, 2011 Landauer, Inc. (NYSE: LDR ... quarterly cash dividend of $0.55 per share for the second quarter ... 2011, to shareholders of record on March 11, 2011. ... provider of technical and analytical services to determine occupational and environmental ...
Cached Medicine Technology:Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 2Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 3Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 4
... The Smith & Nephew ECTRA II ... release the carpal tunnel ligament endoscopically, allowing ... proximal cutting, while minimizing endoscopic lens fogging ... the surgeon complete visualization and control. ECTRA ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... Cross-Screw System offers the surgeon ... for ACL reconstruction utilizing soft ... System provides the latest technology ... comes in Titanium as well ...
Medicine Products: